tryptophan has been researched along with Diabetic Nephropathies in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 6 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjornstad, P; Cara-Fuentes, G; Cherney, D; Chung, LT; Johnson, RJ; Lanaspa, MA; MacDonald, A; Melena, I; Nadeau, KJ; Nelson, RG; Parikh, CR; Pavkov, ME; Piani, F; Pyle, L; Rewers, A; Roncal-Jimenez, CA; Severn, C; Tommerdahl, KL; van Raalte, DH; Vinovskis, C | 1 |
| Ai, SS; Cui, T; Gao, RR; Han, C; Hu, HZ; Li, W; Liu, Y; Shen, Z; Sui, GY | 1 |
| Debnath, S; Grant, S; Kasinath, BS; Kottewar, S; Lorenzo, C; Saliba, A; Sharma, K; Thomas, N | 1 |
| Cui, H; Li, H; Lv, S; Ma, Z; Pan, B; Sun, W; Wang, L; Wang, Y; Xu, K; Zhang, H; Zhang, T | 1 |
| Benvenga, S; Bolignano, D; Buemi, M; Cernaro, V; Cigala, RM; Crea, F; De Stefano, C; Ferlazzo, VT; Gembillo, G; Genovese, ARR; Loddo, S; Macaione, V; Santoro, D; Vita, R | 1 |
| Cui, W; Guo, R; Shang, J; Wang, L; Xiao, J; Zhang, F; Zhao, Z | 1 |
| Chen, IW; Chen, ST; Chiu, DT; Chou, CA; Lin, CN | 1 |
| Antoniadi, G; Eleftheriadis, T; Liakopoulos, V; Pissas, G; Stefanidis, I; Tsogka, K | 1 |
| Kalim, S; Rhee, EP | 1 |
| Kogure, A; Kondo, M; Nakamura, Y; Sakane, N; Takakura, Y; Umekawa, T; Yoshida, T; Yoshioka, K | 1 |
| Grzeszczak, W; Labuz, B; Lacka, B; Saucha, W; Szydlowska, I; Zukowska-Szczechowska, E; Zychma, MJ | 1 |
| Baba, T; Nakajima, S | 1 |
1 review(s) available for tryptophan and Diabetic Nephropathies
| Article | Year |
|---|---|
An overview of renal metabolomics.
Topics: Acute Kidney Injury; Analytic Sample Preparation Methods; Cardiovascular Diseases; Diabetic Nephropathies; Humans; Kidney; Magnetic Resonance Spectroscopy; Mass Spectrometry; Metabolome; Metabolomics; Methylamines; Mitochondria; Renal Insufficiency, Chronic; Tryptophan | 2017 |
11 other study(ies) available for tryptophan and Diabetic Nephropathies
| Article | Year |
|---|---|
Aminoaciduria and metabolic dysregulation during diabetic ketoacidosis: Results from the diabetic kidney alarm (DKA) study.
Topics: Adolescent; Amino Acids; Child; Creatinine; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Diabetic Nephropathies; Female; Histidine; Humans; Leucine; Male; Threonine; Tryptophan | 2022 |
Yi-Shen-Hua-Shi granule ameliorates diabetic kidney disease by the "gut-kidney axis".
Topics: Animals; Blood Glucose; Chromatography, Liquid; Diabetes Mellitus; Diabetic Nephropathies; Glucose; Glycerophospholipids; Herbal Medicine; Kidney; Rats; Saline Solution; Sphingolipids; Tandem Mass Spectrometry; Tryptophan; Valsartan | 2023 |
Tryptophan metabolites and anemia in patients with diabetic kidney disease.
Topics: Anemia; Diabetes Mellitus; Diabetic Nephropathies; Humans; Tryptophan | 2023 |
Topics: Animals; Apoptosis; Diabetes Mellitus; Diabetic Nephropathies; Ferroptosis; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rosa; Signal Transduction; Tryptophan | 2023 |
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Angiotensins; Correlation of Data; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kynurenine; Male; Renal Insufficiency, Chronic; Renin; Tryptophan | 2020 |
Untargeted serum metabolomics and tryptophan metabolism profiling in type 2 diabetic patients with diabetic glomerulopathy.
Topics: Adult; Case-Control Studies; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Linear Models; Male; Metabolic Networks and Pathways; Metabolomics; Middle Aged; Tryptophan | 2021 |
Tryptophan as a surrogate prognostic marker for diabetic nephropathy.
Topics: Adult; Biomarkers; Diabetic Nephropathies; Disease Progression; Female; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Sensitivity and Specificity; Tryptophan | 2018 |
Activation of general control nonderepressible 2 kinase protects human glomerular endothelial cells from harmful high-glucose-induced molecular pathways.
Topics: Blood Glucose; Cells, Cultured; Diabetic Nephropathies; Glucose Transporter Type 1; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Peptide Fragments; Protective Factors; Protein Kinase C; Tryptophan; Urothelium | 2016 |
Trp64Arg mutation of beta3-adrenoceptor gene is associated with diabetic nephropathy in Type II diabetes mellitus.
Topics: Aged; Arginine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Mutation; Receptors, Adrenergic, beta; Tryptophan | 1998 |
Is Trp64Arg polymorphism of beta3-adrenergic receptor a clinically useful marker for the predisposition to diabetic nephropathy in Type II diabetic patients?
Topics: Arginine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Genetic Markers; Humans; Receptors, Adrenergic, beta; Tryptophan | 1999 |
Trp64Arg polymorphism of the beta3-adrenergic receptor is not associated with diabetic nephropathy in Japanese patients with type 2 diabetes.
Topics: Albuminuria; Amino Acid Substitution; Arginine; Asian People; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Genotype; Humans; Japan; Male; Middle Aged; Polymorphism, Genetic; Proteinuria; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Tryptophan | 2000 |